Sirna compositions and methods targeting microtubule associated protein tau nucleic acids
MYPI2025001880A0Undetermined Publication Date: 2024-03-29ATALANTA THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025001880
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-09-29
- Filing Date
- 2023-09-28
- Publication Date
- 2024-03-29
Smart Images

Figure PI2025001880_DRAWING_001 
Figure PI2025001880_DRAWING_002 
Figure PI2025001880_DRAWING_003
Abstract
The instant application is directed to single- or double-stranded interfering RNA molecules (e.g., siRNA) that target a microtubule-associated protein tau (MAPI) gene. The interfering RNA molecules may contain specific patterns of nucleoside modifications and internucleoside linkage modifications, as pharmaceutical compositions including the same. The siRNA molecules may be branched siRNA molecules, such as di-branched, tri-branched, or tetra-branched siRNA molecules. The disclosed siRNA molecules may further feature a 5' phosphorus stabilizing moiety and / or a hydrophobic moiety. Additionally, the disclosure provides methods for delivering the siRNA molecule of the disclosure to the central nervous system of a subject, such as a subject identified as having a tauopathy. Fig. 1A
Need to check novelty before this filing date? Find Prior Art
